Revlimid

Medicinal product

(Invented) name

Revlimid

Active substance (s)

Lenalidomidas

Strength

5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2007-06-14

Date of renewal

Documents

Paciento patvirtinimo dokumentas.pdf

Revlimid mokomoji medziaga pacientams.pdf

Revlimid pranesimo apie nestuma forma.pdf

Revlimid mokomoji medziaga sveikatos prieziuros specialistams.pdf

Revlimid paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Lenalidomidas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
28168	30703	1030703	lizdinė plokštelė	N21		Receptinis	EU/1/07/391/001	Netiekiama	-	-	No	-	-
58050	72174	1072174	lizdinė plokštelė	N7		Receptinis	EU/1/07/391/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-06-14	Registruotas